COMMUNIQUÉS West-GlobeNewswire

-
Syndax Reports First Quarter 2025 Financial Results and Provides Business Update
05/05/2025 -
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
05/05/2025 -
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
05/05/2025 -
Solésence Reports Record First Quarter 2025 Financial Results
05/05/2025 -
Evolved Extraction Solutions Announces Strategic Expansion in U.S. Market Amid Industry Shakeup
05/05/2025 -
DrEO Clinic Named Best Hair Transplant Clinic in Mexico for 2025, Leading the Way in Affordable Medical Tourism
05/05/2025 -
Robert Olsen Receives Individual Achievement Award from the Healthcare Financial Management Association
05/05/2025 -
IBA – ACQUISITION OF OWN SHARES
05/05/2025 -
IBA – ACQUISITION D’ACTIONS PROPRES
05/05/2025 -
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
05/05/2025 -
OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab
05/05/2025 -
OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab
05/05/2025 -
Cuprina Holdings Announces Completion, Receipt of Certification and License, for IVF Media Production Facility Built in Collaboration with Ferti-Craft Pte Ltd.
05/05/2025 -
Cuprina Holdings (Cayman) Limited Announces Closing of Initial Public Offering
05/05/2025 -
Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering
05/05/2025 -
AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting
05/05/2025 -
AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA
05/05/2025 -
Coloplast A/S CEO Kristian Villumsen steps down as of today
05/05/2025 -
Arialief Reviews (CRITICAL INVESTIGATION) What Doctors Say About Arialief's Safety And Complaints!
05/05/2025
Pages